Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Archives of Gynecology and Obstetrics
Published in: Archives of Gynecology and Obstetrics 3/2019

01-03-2019 | Streptococci | Maternal- Fetal Medicine

Prevalence of colonisation by group B streptococcus in pregnant patients in Taguatinga, Federal District, Brazil: a cross-sectional study

Authors: Fábio Siqueira, Eli Mendes Ferreira, Iracema de Matos Calderon, Adriano Dias

Published in: Archives of Gynecology and Obstetrics | Issue 3/2019

Login to get access

Abstract

Propose

Group B streptococcus is responsible for severe infections in neonates resulting from vertical transmission from pregnant women colonized in the anal, perineal or vaginal regions. The identification of colonized patients and use of intrapartum prophylaxis may reduce the risk of neonatal infection.

Methods

A cross-sectional study of pregnant women of gestational age between 35 and 37 weeks was conducted. Material was collected from patients for laboratory identification of group B streptococcus. Epidemiological data, including weight, height, body mass index, antibiotic use during pregnancy, pathologies during pregnancy (diabetes, hypertensive diseases, and hypothyroidism), twinning, and others, were also collected from patients.

Results

The sample consisted of 501 pregnant women, and the prevalence of group B streptococcus was 14%. The mean age was 29 years, and the mean BMI was 30.7. During pregnancy, 204 patients had some type of infection, and 201 used antibiotics. Ninety-five patients were diagnosed with gestational diabetes mellitus and 74 with some type of hypertensive disease.

Conclusions

The prevalence of group B streptococcus observed did not differ from that observed in other studies. None of the factors studied can be considered as risk or protective factors for maternal colonization by group B streptococcus.
Literature
1.
Shah M, Aziz N, Leva N, Cohan D (2011) Group B Streptococcus colonization by HIV status in pregnant women: prevalence and risk factors. J Womens Health (Larchmt) 20(11):1737–1741CrossRef
2.
de-Paris F, Mombach AB, Machado P, Gheno TC, Ascoli BM, Oliveira KR et al (2011) Group B Streptococcus detection: comparison of PCR assay and culture as a screening method for pregnant women. Braz J Infect Dis 15(4):323–327CrossRef
3.
Dyke MKV, Phares CR, Lynfield R, Thomas AR, Arnold KE, Craig AS et al (2009) Evaluation of universal antenatal screening for group B streptococcus. N Engl J Med 360:2626–2636CrossRef
4.
Busetti M, D’Agaro P, Campello C (2007) Group B streptococcus prevalence in pregnant women from North-Eastern Italy: advantages of a screening strategy based on direct plating plus broth enrichment. J Clin Pathol 60:1140–1143CrossRef
5.
Konrad G, Katz A (2007) Épidémiologie de l’infection néonatale à streptocoques du groupe B à début précoce. Can Fam Physician 53:1054–1055PubMedCentral
6.
Berardi A, Rossi C, Guidotti I, Vellani G, Lugli L, Bacchi Reggiani ML et al (2014) Factors associated with intrapartum transmission of group B Streptococcus. Pediatr Infect Dis J 33(12):1211–1215CrossRef
7.
Sakata H (2012) Evaluation of intrapartum antibiotic prophylaxis for the prevention of early-onset group B streptococcal infection. J Infect Chemother 18(6):853–857CrossRef
8.
Hiller JE, McDonald HM, Darbyshire P, Crowther CA (2005) Antenatal screening for group B streptococcus: a diagnostic cohort study. BMC Pregnancy Childbirth 5:12CrossRef
9.
El Aila NA, Tency I, Claeys G, Saerens B, Cools P, Verstraelen H et al (2010) Comparison of different sampling techniques and of different culture methods for detection of group B streptococcus carriage in pregnant women. BMC Infect Dis 10:285CrossRef
10.
Le Doare K, Heath PT (2013) An overview of global GBS epidemiology. Vaccine 31(Suppl 4):D7–D12CrossRef
11.
Verani JR, McGee L, Schrag SJ (2010) Prevention of perinatal group B streptococcal disease–revised guidelines from CDC, 2010. MMWR Recomm Rep 59(RR-10):1–36PubMed
12.
Krohn MA, Hillier SL, Baker CJ (1999) Maternal peripartum complications associated with vaginal group B streptococci colonization. J Infect Dis 179(6):1410–1415CrossRef
13.
Função JM, Narchi NZ (2013) A study of group B streptococcus in pregnant women of eastern Sao Paulo. Rev Esc Enfer USP 47(1):22–29CrossRef
14.
Edwards MS, Gonik B (2012) Preventing the broad spectrum of perinatal morbidity and mortality through group B streptococcal vaccination. Vaccine 31(Supp 4):D66–71PubMed
15.
Schrag SJ, Verani JR (2013) Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the US and implications for a potential group B streptococcal vaccine. Vaccine 31(Suppl 4):D20–D26CrossRef
16.
Barcaite E, Bartusevicius A, Tameliene R, Maleckiene L, Vitkauskiene A, Nadisauskiene R (2012) Group B streptococcus and Escherichia coli colonization in pregnant women and neonates in Lithuania. Int J Gynaecol Obstet 117(1):69–73CrossRef
17.
Numanovic F, Smajlovic J, Gegic M, Delibegovic Z, Bektas S, Halilovic E et al (2017) Presence and resistance of Streptococcus agalactiae in vaginal specimens of pregnant and adult non-pregnant women and association with other aerobic bacteria. Med Glas (Zenica) 14(1):98–105
18.
Khan MA, Faiz A, Ashshi AM (2015) Maternal colonization of group B streptococcus: prevalence, associated factors and antimicrobial resistance. Ann Saudi Med 35(6):423–427CrossRef
19.
Le Doare K, Jarju S, Darboe S, Warburton F, Gorringe A, Heath PT et al (2016) Risk factors for group B streptococcus colonisation and disease in Gambian women and their infants. J Infect 72(3):283–294CrossRef
20.
Krasnianin E, Skret-Magierlo J, Witalis J, Barnas E, Kluz T, Koziel A et al (2009) The incidence of streptococcus group B in 100 parturient women and the transmission of pathogens to the newborn. Ginekol Pol 80(4):285–289PubMed
21.
Brzychczy-Wloch M, Wojkowska-Mach J, Helwich E, Heczko PB (2013) Incidence of maternal GBS colonization and neonatal GBS disease among very low birth weight Polish neonates. Med Sci Monit 19:34–39CrossRef
22.
Mengist A, Kannan H, Abdissa A (2016) Prevalence and antimicrobial susceptibility pattern of anorectal and vaginal group B Streptococci isolates among pregnant women in Jimma, Ethiopia. BMC Res Notes 9:351CrossRef
23.
Capanna F, Emonet SP, Cherkaoui A, Irion O, Schrenzel J, Martinez de Tejada B (2013) Antibiotic resistance patterns among group B Streptococcus isolates: implications for antibiotic prophylaxis for early-onset neonatal sepsis. Swiss Med Wkly 143:w13778PubMed
24.
Miyata A, Takahashi H, Kubo T, Watanabe N, Tsukamoto K, Ito Y et al (2012) Early-onset group B streptococcal disease following culture-based screening in Japan: a single center study. J Obstet Gynaecol Res 38(8):1052–1056CrossRef
25.
Beraldo C, Brito ASJ, Saridakis HO, Matsuo T (2004) Prevalência da colonização vaginal e anorretal por estreptococo de grupo B em gestantes do terceiro trimestre. Rev Bras Ginecol Obstet 26(7):543–549CrossRef
26.
Alves VMN, Simões JA (2005) Prevalência e fatores associados ã colonização retal e vaginal pelo estreptococo do grupo B em parturientes e suas características fenotípicas—Resumo de Tese. Rev Bras Ginecol Obstet 27(7):435CrossRef
27.
Pogere A, Soccoli CM, Tobouti NR, Freitas PF, d’Acampora AJ, Zunino JN (2005) Prevalência da colonização pelo estreptococo do grupo B em gestantes atendidas em ambulatório de pré-natal. Rev Bras Ginecol Obstet 27(4):174–180
28.
Zusman AS, Baltimore RS, Fonseca SN (2006) Prevalence of maternal group B streptococcal colonization and related risk factors in a Brazilian population. Braz J Infect Dis 10(4):242–246CrossRef
29.
Costa ALR, Filho FL, Chein MBC, Brito LMO, Lamy SC, Andrade KL (2008) Prevalência de colonização por estretococos do grupo B em gestantes antedndidas em maternidade pública da região Nordeste do Brasil. Rev Bras Ginecol Obstet 30(8):274–280CrossRef
30.
Nomura ML, Passini Junior R, Oliveira UM, Calil R (2009) Group B streptococcus maternal and neonatal colonization in preterm rupture of membranes and preterm labor. Rev Bras Ginecol Obstet 31(8):397–403CrossRef
31.
Soares GC, Alviano DS, da Silva Santos G, Alviano CS, Mattos-Guaraldi AL, Nagao PE (2013) Prevalence of group B streptococcus serotypes III and V in pregnant women of Rio de Janeiro, Brazil. Braz J Microbiol 44(3):869–872CrossRef
32.
Melo SC, Santos NC, Oliveira M, Scodro RB, Cardoso RF, Padua RA et al (2016) Antimicrobial susceptibility of streptococcus agalactiae isolated from pregnant women. Rev Inst Med Trop Sao Paulo 58:83CrossRef
33.
Johri AK, Lata H, Yadav P, Dua M, Yang Y, Xu X et al (2013) Epidemiology of group B streptococcus in developing countries. Vaccine 31(Suppl 4):D43–D45CrossRef
34.
Dutra VG, Alves VM, Olendzki AN, Dias CA, de Bastos AF, Santos GO et al (2014) Streptococcus agalactiae in Brazil: serotype distribution, virulence determinants and antimicrobial susceptibility. BMC Infect Dis 14:323CrossRef
35.
Edmond KM, Kortsalioudaki C, Scott S, Schrag S, Zaidi AK, Cousens S et al (2012) Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet 379(9815):547–556CrossRef
36.
Fröhlicher S, Reichen-Fahrni G, Muller M, Surbek D, Droz S, Spellerberg B et al (2014) Serotype distribution and antimicrobial susceptibility of group B streptococci in pregnant women: results from a Swiss tertiary centre. Swiss Med Wkly 144:w13935PubMed
37.
Brzychczy-Wloch M, Gosiewski T, Bulanda M (2014) Multilocus sequence types of invasive and colonizing neonatal group B streptococci in Poland. Med Princ Pract 23(4):323–330CrossRef
38.
Bekker V, Bijlsma MW, van de Beek D, Kuijpers TW, van der Ende A (2014) Incidence of invasive group B streptococcal disease and pathogen genotype distribution in newborn babies in the Netherlands over 25 years: a nationwide surveillance study. Lancet Infect Dis 14(11):1083–1089CrossRef
39.
Lu B, Li D, Cui Y, Sui W, Huang L, Lu X (2014) Epidemiology of group B streptococcus isolated from pregnant women in Beijing, China. Clin Microbiol Infect 20(6):O370–O373CrossRef
40.
Poulain P, Betremieux P, Donnio PY, Proudhon JF, Karege G, Giraud JR (1997) Selective intrapartum anti-bioprophylaxy of group B streptococci infection of neonates: a prospective study in 2454 subsequent deliveries. Eur J Obstet Gynecol Reprod Biol 72(2):137–140CrossRef
41.
Bianco A, Larosa E, Pileggi C, Pavia M, Collaborative Working Group (2016) Appropriateness of intrapartum antibiotic prophylaxis to prevent neonatal group B streptococcus disease. PLoS ONE 11(11):e0166179CrossRef
42.
43.
Secretaria Municipal da Saúde (2017) Nota Técnica prevenção da infecção neonatal pelo streptococcus agalactiae. In: Áreas técnicas da saúde da mulher e da criança, Secretaria Municipal da Saúde, São Paulo
44.
Silva JM, Stein AT, Schunemann HJ, Bordin R, Kuchenbecker R, de Lourdes Drachler M (2013) Academic detailing and adherence to guidelines for group B streptococci prenatal screening: a randomized controlled trial. BMC Pregnancy Childbirth 13:68CrossRef
45.
Ministério da Saúde (2014) Direito de informação da gestante e obrigatoriedade do cartão da gestante, carta de informação de partograma na saúde suplementar. In: Agência Nacional de Saúde Complementar, Ministério da Saúde, Brasília
46.
IPEA (2014) Objetivos de Desenvolvimento do Milênio: Relatório Nacional de Acompanhamento. In: Instituto de Pesquisa Econômica Aplicada e Secretaria de Manejamento e Investimentos Estratégicos, editor. : IPEA, Brasília
47.
Ministério da Saúde (2014) Política Nacional de Atenção Integral à Saúde da Mulher: princípios e diretrizes. In: Secretaria de Atenção à Saúde, Ministério da Saúde
48.
Brasil (2003) Urgências e Emergências Maternas. Secretaria de Políticas de Saúde, Área Técnica da Saúde da Mulher, Ministério da Saúde
49.
Sullivan KM, Dean A, Soe MM (2009) OpenEpi: a web-based epidemiologic and statistical calculator for public health. Public Health Rep 124(3):471–474CrossRef
50.
Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A (2002) Prevention of perinatal group B streptococcal disease Revised guidelines from CDC. MMWR Recomm Rep 51(RR-11):1–22PubMed
51.
CDC (1996) Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR Recomm Rep 45(RR-7):1–24
52.
Alos-Cortes JI, Andreu-Domingo A, Arribas-Mir L, Cabero-Roura L, de Cueto-Lopez M, Lopez-Sastre J et al (2013) Prevention of neonatal group B sreptococcal infection. Spanish recommendations update 2012 SEIMC/SEGO/SEN/SEQ/SEMFYC consensus document. Enferm Infecc Microbiol Clin 31(3):159–172CrossRef
53.
Bryant AS, Cheng YW, Caughey AB (2011) Equality in obstetrical care: racial/ethnic variation in group B streptococcus screening. Matern Child Health J 15(8):1160–1165CrossRef
54.
David W, Hosmer J, Lemeshow S (2005) Applied logistic regression. 2nd Edn. Hoboken, NJ, Wiley
55.
Ueno H, Yamamoto Y, Yamamichi A, Kikuchi K, Kobori S, Miyazaki M (2012) Characterization of group B streptococcus isolated from women in Saitama city, Japan. Jpn J Infect Dis 65(6):516–521CrossRef
56.
Capraro GA, Rambin ED, Vanchiere JA, Bocchini JA Jr, Matthews-Greer JM (2013) High rates of inducible clindamycin resistance among prenatal group B streptococcal isolates in one northwest Louisiana academic medical center. J Clin Microbiol 51(7):2469CrossRef
57.
Lee WT, Lai MC (2014) High prevalence of Streptococcus agalactiae from vaginas of women in Taiwan and its mechanisms of macrolide and quinolone resistance. J Microbiol Immunol Infect 48(5):510–516CrossRef
58.
Yeung SW, Sahota DS, Leung TY (2014) Comparison of the effect of penicillins versus erythromycin in preventing neonatal group B streptococcus infection in active carriers following preterm prelabor rupture of membranes. Taiwan J Obstet Gynecol. 53(2):210–214CrossRef
Metadata
Title
Prevalence of colonisation by group B streptococcus in pregnant patients in Taguatinga, Federal District, Brazil: a cross-sectional study
Authors
Fábio Siqueira
Eli Mendes Ferreira
Iracema de Matos Calderon
Adriano Dias
Publication date
01-03-2019
Publisher
Springer Berlin Heidelberg
Published in
Archives of Gynecology and Obstetrics / Issue 3/2019
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-019-05040-z

Other articles of this Issue 3/2019

Archives of Gynecology and Obstetrics 3/2019 Go to the issue

Maternal-Fetal Medicine

Epidemiology of mental disorders during pregnancy and link to birth outcome: a large-scale retrospective observational database study including 38,000 pregnancies

Maternal-Fetal Medicine

Dosing interval between mifepristone and misoprostol in second and third trimester termination

Gynecologic Endocrinology and Reproductive Medicine

PGR and PTX3 gene expression in cumulus cells from obese and normal weighting women after administration of long-acting recombinant follicle-stimulating hormone for controlled ovarian stimulation

Gynecologic Endocrinology and Reproductive Medicine

Using time-lapse technology to explore vacuolization in embryos on Day 3 and Day 4

Maternal- Fetal Medicine

Association between serum beta-human chorionic gonadotropin and preeclampsia and its effects on perinatal and maternal outcomes: a case control study

Gynecologic Oncology

Sec62/Ki67 and p16/Ki67 dual-staining immunocytochemistry in vulvar cytology for the identification of vulvar intraepithelial neoplasia and vulvar cancer: a pilot study